Black leo med tech
Are You A Business Leader Seeking
An Exit Or A StrategicPartnership?
We're Buying
Black leo med tech
Are You A Business Leader
Seeking An Exit Or A Strategic
Partnership?
We're Buying
![](https://blackleomedtech.com/wp-content/uploads/2023/07/Mask-Group-84.png)
Black leo med tech
Are You A Business Leader Seeking An Exit Or A Strategic Partnership?
We're Buying.
Investment Criteria
Revenue Range
30-300 Cr
EBITDA MARGIN +15%
Vision
To consolidate the Healthcare and
Phamaceutical space and be
a dominant force in determining the
future of the industry.
To consolidate the Healthcare and Phamaceutical space and be a dominant force in determining the future of the industry.
Opportunity
For Investors
To create and operate a black swan event.
For Owners Seeking Exit
Great exit options or a chance to be a part of
a recession proof venture.
Annual Revenue
30 Cr- 300 Cr
![](https://blackleomedtech.com/wp-content/uploads/2023/07/Annual-Revenue-Icon.png)
For bigger deals, we're open
to invest with big players.
Location
India
![](https://blackleomedtech.com/wp-content/uploads/2023/07/Location-India-Icon.png)
![](https://blackleomedtech.com/wp-content/uploads/2023/07/Logo-Icon.png)
Industry
Healthcare
Other financial acquisitions may be
considered on a case-by-case basis.
Exit
5-7 years
With a valuation of +$2 Bilion.
Annual Revenue
![](https://blackleomedtech.com/wp-content/uploads/2023/07/Annual-Revenue-Icon.png)
30 Cr- 300 Cr
For bigger deals, we're open
to invest with big players.
Location
![](https://blackleomedtech.com/wp-content/uploads/2023/07/Location-India-Icon.png)
India
![](https://blackleomedtech.com/wp-content/uploads/2023/07/Logo-Icon.png)
Industry
Healthcare
Other financial acquisitions may be
considered on a case-by-case basis.
Exit
5-7 years
With a valuation of +$2 Bilion.
Long Term Plan
Year 2023
Consolidation in
Pharmaceuticals with $35 milion in equity value.
2023 & Beyond
Consolidation of different verticals across South-East Asia.
Exit
A diverstiture, private sell off or public listing. We'll let the market dictate 5-7 years from now.
Year 2023
Consolidation in Pharmaceuticals with $35 milion in equity value.
2023 & Beyond
Consolidation of different verticals across South-East Asia.
Exit
A diverstiture, private sell off or public listing. We'll let the market dictate 5-7 years from now.
Long Term Plan
Year 2023
Consolidation in
Pharmaceuticals with $35
milion in equity value.
2023 & Beyond
Consolidation of different
verticals across
South-East Asia.
Exit
A diverstiture, private sell off
or public listing. We'll let the
market dictate 5-7 years
from now.
Board of Directors
"The first method of measuring the intelligence of a ruler is to look at the men he surrounds himself with" - Niccolo Machiavelli
"The first method of measuring the intelligence of a ruler is to look at the men he surrounds himself with" - Niccolo Machiavelli
![](https://blackleomedtech.com/wp-content/uploads/2023/07/Utkarsh-Chourasiya.png)
Utkarsh Chourasiya
Co-Founder, M&A director
![](https://blackleomedtech.com/wp-content/uploads/2023/07/Nirdosh-Arora.png)
Nirdosh Arora
Co-Founder, Business development
Rajendra Patkar
37+ Years of Experience
In The Pharmaceutical Space, The Best
There Is To Run A Multi-Milion Dollar Company.
There Is To Run A Multi-Milion Dollar Company.
![](https://blackleomedtech.com/wp-content/uploads/2023/07/Utkarsh-Chourasiya.png)
Utkarsh Chourasiya
Co-Founder, M&A director
![](https://blackleomedtech.com/wp-content/uploads/2023/07/Nirdosh-Arora.png)
Nirdosh Arora
Co-Founder, Business development
Rajendra Patkar
37+ Years of Experience
In The Pharmaceutical Space, The Best
There Is To Run A Multi-Milion Dollar Company.
There Is To Run A Multi-Milion Dollar Company.